Please login (Members) to view content or
(Nonmembers) this article.

No votes yet


Home-Based Lymphedema Treatment in Patients With Cancer-Related Lymphedema or Noncancer-Related Lymphedema

Sheila H. Ridner
Elizabeth McMahon
Mary S. Dietrich
Sunday Hoy
ONF 2008, 35(4), 671-680 DOI: 10.1188/08.ONF.671-680

Purpose/Objectives: To compare treatment protocol adherence, satisfaction, and perceived changes in emotional and functional status between patients with lymphedema with and without cancer using the home-based Flexitouch® (Tactile Systems Technology, Inc.) system for lymphedema self-care.

Design: Quasi-experimental, pre- and post-test design.

Setting: Private homes in the continental United States and Alaska.

Sample: 155 community-dwelling individuals with lymphedema: 93 with cancer-related lymphedema and 62 with noncancer-related lymphedema.

Methods: A survey was completed before use of the Flexitouch system. Participants received in-home education about device use, safety precautions, and the two-phase therapy protocol. A post-therapy survey was completed during the maintenance phase of the protocol.

Main Research Variables: Use of the Flexitouch system, treatment protocol adherence, participant satisfaction, and emotional and functional status.

Findings: Participants without cancer were more adherent to the prescribed protocol. Both groups were satisfied with the system, perceived it to be effective, and reported improvement in physical and emotional status. Participants' use of professional manual lymphatic drainage (MLD) therapy, self-MLD, and bandaging declined after they initiated use of the Flexitouch system.

Conclusions: Patients using the Flexitouch system were satisfied with the device and perceived it to be beneficial in management of their lymphedema.

Implications for Nursing: Patients using the Flexitouch system should be assessed for adherence to the prescribed treatment protocol and use of other self-care treatments. Healthcare professionals should facilitate communication among members of the lymphedema treatment team and the patient when problems are noted.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or